C
Aehr Test Systems, Inc.
AEHR
$8.78
-$0.10-1.13%
C
Hold
11/11/2024Downgrade
Aehr Test Systems, Inc. (AEHR) was downgraded to C- from C on 11/11/2024 due to a significant decline in the growth index, total return index and efficiency index. Earnings per share declined from $0.8138 to $0.02, net income declined 97.23% from $23.86M to $660, and EBIT declined 93.74% from $2.54M to $159.
Aehr Test Systems, Inc. (AEHR) was downgraded to C- from C on 11/11/2024 due to a significant decline in the growth index, total return index and efficiency index. Earnings per share declined from $0.8138 to $0.02, net income declined 97.23% from $23.86M to $660, and EBIT declined 93.74% from $2.54M to $159.
C
Hold
7/31/2024Upgraded
Aehr Test Systems, Inc. (AEHR) was upgraded to C from C- on 7/31/2024 due to a significant increase in the growth index, valuation index and efficiency index. Net income increased 1,722.3% from -$1.47M to $23.86M, earnings per share increased from -$0.051 to $0.8138, and EBIT increased 224.19% from -$2.05M to $2.54M.
Aehr Test Systems, Inc. (AEHR) was upgraded to C from C- on 7/31/2024 due to a significant increase in the growth index, valuation index and efficiency index. Net income increased 1,722.3% from -$1.47M to $23.86M, earnings per share increased from -$0.051 to $0.8138, and EBIT increased 224.19% from -$2.05M to $2.54M.
C
Hold
4/11/2024Downgrade
Aehr Test Systems (AEHR) was downgraded to C- from C on 4/11/2024 due to a significant decline in the growth index, valuation index and efficiency index. Operating cash flow declined 418.17% from -$545 to -$2.82M, EBIT declined 137.42% from $5.47M to -$2.05M, and earnings per share declined from $0.2 to -$0.051.
Aehr Test Systems (AEHR) was downgraded to C- from C on 4/11/2024 due to a significant decline in the growth index, valuation index and efficiency index. Operating cash flow declined 418.17% from -$545 to -$2.82M, EBIT declined 137.42% from $5.47M to -$2.05M, and earnings per share declined from $0.2 to -$0.051.
C
Hold
1/31/2024Downgrade
Aehr Test Systems (AEHR) was downgraded to C from C+ on 1/31/2024 due to a decline in the total return index and volatility index.
Aehr Test Systems (AEHR) was downgraded to C from C+ on 1/31/2024 due to a decline in the total return index and volatility index.
C
Hold
1/16/2024Upgraded
Aehr Test Systems (AEHR) was upgraded to C+ from C on 1/16/2024 due to a major increase in the growth index, valuation index and efficiency index. EBIT increased 32.88% from $4.12M to $5.47M, net income increased 30.27% from $4.67M to $6.09M, and earnings per share increased from $0.16 to $0.2.
Aehr Test Systems (AEHR) was upgraded to C+ from C on 1/16/2024 due to a major increase in the growth index, valuation index and efficiency index. EBIT increased 32.88% from $4.12M to $5.47M, net income increased 30.27% from $4.67M to $6.09M, and earnings per share increased from $0.16 to $0.2.
C
Hold
11/10/2023Downgrade
Aehr Test Systems (AEHR) was downgraded to C from C+ on 11/10/2023 due to a substantial decline in the total return index, growth index and volatility index. Operating cash flow declined 33.52% from $5.87M to $3.9M, EBIT declined 27.03% from $5.64M to $4.12M, and earnings per share declined from $0.2088 to $0.16.
Aehr Test Systems (AEHR) was downgraded to C from C+ on 11/10/2023 due to a substantial decline in the total return index, growth index and volatility index. Operating cash flow declined 33.52% from $5.87M to $3.9M, EBIT declined 27.03% from $5.64M to $4.12M, and earnings per share declined from $0.2088 to $0.16.
C
Hold
10/3/2023Downgrade
Aehr Test Systems (AEHR) was downgraded to C+ from B- on 10/3/2023 due to a decline in the total return index.
Aehr Test Systems (AEHR) was downgraded to C+ from B- on 10/3/2023 due to a decline in the total return index.
B
Buy
9/14/2023Upgraded
Aehr Test Systems (AEHR) was upgraded to B- from C+ on 9/14/2023 due to a noticeable increase in the efficiency index, growth index and solvency index. Operating cash flow increased 622.53% from -$1.12M to $5.87M, earnings per share increased from $0.14 to $0.2088, and EBIT increased 48.67% from $3.79M to $5.64M.
Aehr Test Systems (AEHR) was upgraded to B- from C+ on 9/14/2023 due to a noticeable increase in the efficiency index, growth index and solvency index. Operating cash flow increased 622.53% from -$1.12M to $5.87M, earnings per share increased from $0.14 to $0.2088, and EBIT increased 48.67% from $3.79M to $5.64M.
C
Hold
6/20/2023Downgrade
Aehr Test Systems (AEHR) was downgraded to C+ from B- on 6/20/2023 due to a decline in the total return index and valuation index.
Aehr Test Systems (AEHR) was downgraded to C+ from B- on 6/20/2023 due to a decline in the total return index and valuation index.
B
Buy
6/5/2023Upgraded
Aehr Test Systems (AEHR) was upgraded to B- from C+ on 6/5/2023 due to a substantial increase in the total return index and volatility index.
Aehr Test Systems (AEHR) was upgraded to B- from C+ on 6/5/2023 due to a substantial increase in the total return index and volatility index.
C
Hold
5/1/2023Downgrade
Aehr Test Systems (AEHR) was downgraded to C+ from B- on 5/1/2023 due to a substantial decline in the total return index, efficiency index and growth index.
Aehr Test Systems (AEHR) was downgraded to C+ from B- on 5/1/2023 due to a substantial decline in the total return index, efficiency index and growth index.
B
Buy
4/14/2023Upgraded
Aehr Test Systems (AEHR) was upgraded to B- from C+ on 4/14/2023 due to a noticeable increase in the total return index, valuation index and efficiency index. Total capital increased 30.97% from $57.28M to $75.03M, and net income increased 10.93% from $3.73M to $4.13M.
Aehr Test Systems (AEHR) was upgraded to B- from C+ on 4/14/2023 due to a noticeable increase in the total return index, valuation index and efficiency index. Total capital increased 30.97% from $57.28M to $75.03M, and net income increased 10.93% from $3.73M to $4.13M.
C
Hold
3/30/2023Downgrade
Aehr Test Systems (AEHR) was downgraded to C+ from B- on 3/30/2023 due to a large decline in the total return index and valuation index.
Aehr Test Systems (AEHR) was downgraded to C+ from B- on 3/30/2023 due to a large decline in the total return index and valuation index.
B
Buy
3/15/2023Upgraded
Aehr Test Systems (AEHR) was upgraded to B- from C+ on 3/15/2023 due to a large increase in the total return index, valuation index and volatility index.
Aehr Test Systems (AEHR) was upgraded to B- from C+ on 3/15/2023 due to a large increase in the total return index, valuation index and volatility index.
C
Hold
2/23/2023Downgrade
Aehr Test Systems (AEHR) was downgraded to C+ from B- on 2/23/2023 due to a noticeable decline in the valuation index and total return index.
Aehr Test Systems (AEHR) was downgraded to C+ from B- on 2/23/2023 due to a noticeable decline in the valuation index and total return index.
B
Buy
1/17/2023Upgraded
Aehr Test Systems (AEHR) was upgraded to B- from C+ on 1/17/2023 due to a major increase in the growth index, valuation index and total return index. EBIT increased 660.92% from $458 to $3.49M, earnings per share increased from $0.02 to $0.13, and total revenue increased 38.83% from $10.67M to $14.82M.
Aehr Test Systems (AEHR) was upgraded to B- from C+ on 1/17/2023 due to a major increase in the growth index, valuation index and total return index. EBIT increased 660.92% from $458 to $3.49M, earnings per share increased from $0.02 to $0.13, and total revenue increased 38.83% from $10.67M to $14.82M.
C
Hold
1/5/2023Upgraded
Aehr Test Systems (AEHR) was upgraded to C+ from C on 1/5/2023 due to an increase in the valuation index.
Aehr Test Systems (AEHR) was upgraded to C+ from C on 1/5/2023 due to an increase in the valuation index.
C
Hold
11/18/2022Downgrade
Aehr Test Systems (AEHR) was downgraded to C from C+ on 11/18/2022 due to a noticeable decline in the valuation index and total return index.
Aehr Test Systems (AEHR) was downgraded to C from C+ on 11/18/2022 due to a noticeable decline in the valuation index and total return index.
C
Hold
10/17/2022Downgrade
Aehr Test Systems (AEHR) was downgraded to C+ from B- on 10/17/2022 due to a noticeable decline in the growth index and total return index. EBIT declined 92.13% from $5.82M to $458, earnings per share declined from $0.2054 to $0.02, and total revenue declined 47.4% from $20.29M to $10.67M.
Aehr Test Systems (AEHR) was downgraded to C+ from B- on 10/17/2022 due to a noticeable decline in the growth index and total return index. EBIT declined 92.13% from $5.82M to $458, earnings per share declined from $0.2054 to $0.02, and total revenue declined 47.4% from $20.29M to $10.67M.
B
Buy
8/29/2022Upgraded
Aehr Test Systems (AEHR) was upgraded to B- from C on 8/29/2022 due to a significant increase in the total return index, efficiency index and growth index. Net income increased 158.31% from $2.24M to $5.79M, EBIT increased 157.98% from $2.26M to $5.82M, and earnings per share increased from $0.08 to $0.2054.
Aehr Test Systems (AEHR) was upgraded to B- from C on 8/29/2022 due to a significant increase in the total return index, efficiency index and growth index. Net income increased 158.31% from $2.24M to $5.79M, EBIT increased 157.98% from $2.26M to $5.82M, and earnings per share increased from $0.08 to $0.2054.
C
Hold
8/18/2022Upgraded
Aehr Test Systems (AEHR) was upgraded to C from C- on 8/18/2022 due to an increase in the total return index and volatility index.
Aehr Test Systems (AEHR) was upgraded to C from C- on 8/18/2022 due to an increase in the total return index and volatility index.
C
Hold
7/28/2022Downgrade
Aehr Test Systems (AEHR) was downgraded to C- from C on 7/28/2022 due to a decline in the volatility index and valuation index.
Aehr Test Systems (AEHR) was downgraded to C- from C on 7/28/2022 due to a decline in the volatility index and valuation index.
C
Hold
4/18/2022Upgraded
Aehr Test Systems (AEHR) was upgraded to C from D+ on 4/18/2022 due to a significant increase in the growth index, valuation index and efficiency index. EBIT increased 214.64% from $717 to $2.26M, net income increased 212.83% from $717 to $2.24M, and earnings per share increased from $0.0274 to $0.08.
Aehr Test Systems (AEHR) was upgraded to C from D+ on 4/18/2022 due to a significant increase in the growth index, valuation index and efficiency index. EBIT increased 214.64% from $717 to $2.26M, net income increased 212.83% from $717 to $2.24M, and earnings per share increased from $0.0274 to $0.08.
D
Sell
2/18/2022Downgrade
Aehr Test Systems (AEHR) was downgraded to D+ from C- on 2/18/2022 due to a substantial decline in the total return index and volatility index.
Aehr Test Systems (AEHR) was downgraded to D+ from C- on 2/18/2022 due to a substantial decline in the total return index and volatility index.
C
Hold
1/14/2022Upgraded
Aehr Test Systems (AEHR) was upgraded to C- from D on 1/14/2022 due to a significant increase in the efficiency index, solvency index and growth index. EBIT increased 172.21% from -$993 to $717, total capital increased 167.43% from $15.8M to $42.24M, and the quick ratio increased from 1.23 to 2.56.
Aehr Test Systems (AEHR) was upgraded to C- from D on 1/14/2022 due to a significant increase in the efficiency index, solvency index and growth index. EBIT increased 172.21% from -$993 to $717, total capital increased 167.43% from $15.8M to $42.24M, and the quick ratio increased from 1.23 to 2.56.
D
Sell
11/23/2021Upgraded
Aehr Test Systems (AEHR) was upgraded to D from D- on 11/23/2021 due to an increase in the total return index and valuation index.
Aehr Test Systems (AEHR) was upgraded to D from D- on 11/23/2021 due to an increase in the total return index and valuation index.
D
Sell
11/8/2021Downgrade
Aehr Test Systems (AEHR) was downgraded to D- from D on 11/8/2021 due to a decline in the valuation index.
Aehr Test Systems (AEHR) was downgraded to D- from D on 11/8/2021 due to a decline in the valuation index.
D
Sell
2/1/2021Upgraded
Aehr Test Systems (AEHR) was upgraded to D from D- on 2/1/2021 due to an increase in the total return index and volatility index.
Aehr Test Systems (AEHR) was upgraded to D from D- on 2/1/2021 due to an increase in the total return index and volatility index.
D
Sell
1/15/2021Downgrade
Aehr Test Systems (AEHR) was downgraded to D- from D on 1/15/2021 due to a noticeable decline in the growth index, solvency index and total return index. Earnings per share declined from $0.0046 to -$0.084, operating cash flow declined 550.7% from $643 to -$2.9M, and the quick ratio declined from 1.78 to 1.09.
Aehr Test Systems (AEHR) was downgraded to D- from D on 1/15/2021 due to a noticeable decline in the growth index, solvency index and total return index. Earnings per share declined from $0.0046 to -$0.084, operating cash flow declined 550.7% from $643 to -$2.9M, and the quick ratio declined from 1.78 to 1.09.
D
Sell
9/2/2020Downgrade
Aehr Test Systems (AEHR) was downgraded to D from D+ on 9/2/2020 due to a significant decline in the growth index and efficiency index. Earnings per share declined from $0.01 to -$0.1251, net income declined 1,277.55% from $245 to -$2.89M, and EBIT declined 1,127.84% from $255 to -$2.62M.
Aehr Test Systems (AEHR) was downgraded to D from D+ on 9/2/2020 due to a significant decline in the growth index and efficiency index. Earnings per share declined from $0.01 to -$0.1251, net income declined 1,277.55% from $245 to -$2.89M, and EBIT declined 1,127.84% from $255 to -$2.62M.
D
Sell
5/20/2020Upgraded
Aehr Test Systems (AEHR) was upgraded to D+ from D on 5/20/2020 due to a major increase in the growth index, efficiency index and solvency index. The quick ratio increased from 1.66 to 2.58, total capital increased 2.49% from $18.51M to $18.97M, and EBIT increased 2% from $250 to $255.
Aehr Test Systems (AEHR) was upgraded to D+ from D on 5/20/2020 due to a major increase in the growth index, efficiency index and solvency index. The quick ratio increased from 1.66 to 2.58, total capital increased 2.49% from $18.51M to $18.97M, and EBIT increased 2% from $250 to $255.
D
Sell
10/15/2018Downgrade
Aehr Test Systems (AEHR) was downgraded to D from D+ on 10/15/2018 due to a noticeable decline in the growth index, efficiency index and total return index. Earnings per share declined from $0.0087 to -$0.07, net income declined 893.19% from $191 to -$1.52M, and EBIT declined 679.12% from $249 to -$1.44M.
Aehr Test Systems (AEHR) was downgraded to D from D+ on 10/15/2018 due to a noticeable decline in the growth index, efficiency index and total return index. Earnings per share declined from $0.0087 to -$0.07, net income declined 893.19% from $191 to -$1.52M, and EBIT declined 679.12% from $249 to -$1.44M.
D
Sell
8/30/2018Upgraded
Aehr Test Systems (AEHR) was upgraded to D+ from D on 8/30/2018 due to a noticeable increase in the efficiency index, valuation index and solvency index. Debt to equity declined from 0.33 to 0.32, and total capital increased 2.05% from $24.88M to $25.4M.
Aehr Test Systems (AEHR) was upgraded to D+ from D on 8/30/2018 due to a noticeable increase in the efficiency index, valuation index and solvency index. Debt to equity declined from 0.33 to 0.32, and total capital increased 2.05% from $24.88M to $25.4M.
D
Sell
8/31/2017Upgraded
Aehr Test Systems (AEHR) was upgraded to D from D- on 8/31/2017 due to a significant increase in the growth index, solvency index and total return index. The quick ratio increased from 0.77 to 2.77, total revenue increased 149.27% from $2.68M to $6.68M, and operating cash flow increased 99.12% from -$3.05M to -$27.
Aehr Test Systems (AEHR) was upgraded to D from D- on 8/31/2017 due to a significant increase in the growth index, solvency index and total return index. The quick ratio increased from 0.77 to 2.77, total revenue increased 149.27% from $2.68M to $6.68M, and operating cash flow increased 99.12% from -$3.05M to -$27.
D
Sell
3/11/2016Downgrade
Aehr Test Systems (AEHR) was downgraded to D- from D on 3/11/2016 due to a significant decline in the volatility index, total return index and solvency index. Debt to equity increased from 0.71 to 0.81, and the quick ratio declined from 1.2 to 1.07.
Aehr Test Systems (AEHR) was downgraded to D- from D on 3/11/2016 due to a significant decline in the volatility index, total return index and solvency index. Debt to equity increased from 0.71 to 0.81, and the quick ratio declined from 1.2 to 1.07.
D
Sell
4/21/2015Downgrade
Aehr Test Systems (AEHR) was downgraded to D from D+ on 4/21/2015 due to a noticeable decline in the growth index, efficiency index and total return index. Total capital declined 25.97% from $8.14M to $6.02M, total revenue declined 22.49% from $2.62M to $2.03M, and earnings per share declined from -$0.1803 to -$0.14.
Aehr Test Systems (AEHR) was downgraded to D from D+ on 4/21/2015 due to a noticeable decline in the growth index, efficiency index and total return index. Total capital declined 25.97% from $8.14M to $6.02M, total revenue declined 22.49% from $2.62M to $2.03M, and earnings per share declined from -$0.1803 to -$0.14.
D
Sell
10/31/2014Downgrade
Aehr Test Systems (AEHR) was downgraded to D+ from C- on 10/31/2014 due to a decline in the volatility index and valuation index.
Aehr Test Systems (AEHR) was downgraded to D+ from C- on 10/31/2014 due to a decline in the volatility index and valuation index.
C
Hold
10/17/2014Downgrade
Aehr Test Systems (AEHR) was downgraded to C- from C on 10/17/2014 due to a noticeable decline in the volatility index, efficiency index and growth index. EBIT declined 556.81% from $213 to -$973, earnings per share declined from $0.0199 to -$0.08, and net income declined 479.5% from $239 to -$907.
Aehr Test Systems (AEHR) was downgraded to C- from C on 10/17/2014 due to a noticeable decline in the volatility index, efficiency index and growth index. EBIT declined 556.81% from $213 to -$973, earnings per share declined from $0.0199 to -$0.08, and net income declined 479.5% from $239 to -$907.
C
Hold
8/29/2014Upgraded
Aehr Test Systems (AEHR) was upgraded to C from C- on 8/29/2014 due to a noticeable increase in the efficiency index, volatility index and valuation index. Total capital increased 15.32% from $6.77M to $7.81M, and net income increased 12.74% from $212 to $239.
Aehr Test Systems (AEHR) was upgraded to C from C- on 8/29/2014 due to a noticeable increase in the efficiency index, volatility index and valuation index. Total capital increased 15.32% from $6.77M to $7.81M, and net income increased 12.74% from $212 to $239.
C
Hold
6/5/2014Downgrade
Aehr Test Systems (AEHR) was downgraded to C- from C on 6/5/2014 due to a decline in the valuation index.
Aehr Test Systems (AEHR) was downgraded to C- from C on 6/5/2014 due to a decline in the valuation index.
C
Hold
5/21/2014Upgraded
Aehr Test Systems (AEHR) was upgraded to C from C- on 5/21/2014 due to an increase in the valuation index and volatility index.
Aehr Test Systems (AEHR) was upgraded to C from C- on 5/21/2014 due to an increase in the valuation index and volatility index.
C
Hold
4/21/2014Upgraded
Aehr Test Systems (AEHR) was upgraded to C- from D+ on 4/21/2014 due to an increase in the growth index, efficiency index and solvency index. Earnings per share increased from $0.01 to $0.0193, net income increased 54.74% from $137 to $212, and EBIT increased 46.37% from $179 to $262.
Aehr Test Systems (AEHR) was upgraded to C- from D+ on 4/21/2014 due to an increase in the growth index, efficiency index and solvency index. Earnings per share increased from $0.01 to $0.0193, net income increased 54.74% from $137 to $212, and EBIT increased 46.37% from $179 to $262.
NASDAQ
03/13/2025 4:00PM Eastern
Quotes delayed
